• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

改良超长降调节方案可提高卵巢反应不良患者的受精和妊娠率。

Modified super-long down-regulation protocol improves fertilization and pregnancy in patients with poor ovarian responses.

机构信息

Reproductive Medicine Center, Department of Obstetrics and Gynaecology, General Hospital of Tianjin Medical University, Tianjin 300052, China.

出版信息

Chin Med J (Engl). 2012 Aug;125(16):2837-40.

PMID:22932076
Abstract

BACKGROUND

The successful end-point of in vitro fertilization (IVF) treatment is for a woman to give live birth. This outcome is based on various factors including adequate number of retrieved eggs. Failure to recruit adequate follicles, from which the eggs are retrieved, is called a "poor response". How to improve the clinical pregnancy rates of poor responders was one of the tough problems for IVF.

METHODS

The study involved 51 patients who responded poorly to high dose gonadotropin treatment in their previous cycles at our reproductive center, between April 2010 and February 2012. The previous cycle (group A) received routine long protocol; the subsequent cycle (group B) received modified super-long down-regulation protocol. The primary outcome of the study was the number of oocytes fertilized. The increase in the pregnancy rate was the secondary outcome. Differences between the groups were assessed by using Student's t test and c(2) test where appropriate.

RESULTS

The patients' average age was (36.64 ± 3.85) years. The mean duration of ovarian stimulation cycles of the group A patients was longer than those of the group B patients. The total dose of follicle-stimulating hormone (FSH) was significantly lower in the subsequent cycle. The peak value of serum estradiol on human chorionic gonadotrophin (hCG) day was lower in group A as compared with group B. The number of metaphase II oocytes recovered was significantly higher in group B. The cleavage rate in group A was significantly lower than in group B, 49 patients in group B reached embryo transfer stage, while 46 patients in group A reached this stage. Patients in group B received significantly more embryos per transfer as compared with group A. More pregnancies and more clinical pregnancies with fetal heart activity were achieved in group B.

CONCLUSIONS

This comparative trial shows that poor responder women undergoing repeated assisted reproduction treatment using modified super-long down-regulation protocol achieve more oocytes, leading to higher fertilization rate, compared to women receiving routine long protocol. Our study also showed that clinical pregnancy rate was significantly improved.

摘要

背景

体外受精(IVF)治疗的成功终点是女性活产。这一结果基于各种因素,包括足够数量的取卵。未能招募到足够数量的卵泡(卵子从中取出)称为“反应不良”。如何提高反应不良患者的临床妊娠率是 IVF 的难题之一。

方法

本研究纳入了 2010 年 4 月至 2012 年 2 月在我院生殖中心接受高剂量促性腺激素治疗反应不良的 51 例患者。前一周期(A 组)接受常规长方案;随后周期(B 组)接受改良超长降调节方案。本研究的主要结局是受精的卵母细胞数量。次要结局是妊娠率的增加。采用 Student's t 检验和 c(2)检验评估组间差异。

结果

患者平均年龄(36.64 ± 3.85)岁。A 组患者卵巢刺激周期的平均持续时间长于 B 组。随后周期的卵泡刺激素(FSH)总剂量显著降低。hCG 日血清雌二醇的峰值 A 组低于 B 组。B 组回收的中期 II 卵母细胞数量明显高于 A 组。A 组的卵裂率明显低于 B 组,B 组有 49 例患者达到胚胎移植阶段,而 A 组有 46 例患者达到该阶段。B 组患者每次移植接受的胚胎数量明显多于 A 组。B 组的妊娠率和有胎心的临床妊娠率更高。

结论

本对照试验表明,与接受常规长方案的反应不良女性相比,接受改良超长降调节方案重复辅助生殖治疗的反应不良女性获得了更多的卵母细胞,受精率更高。我们的研究还表明,临床妊娠率显著提高。

相似文献

1
Modified super-long down-regulation protocol improves fertilization and pregnancy in patients with poor ovarian responses.改良超长降调节方案可提高卵巢反应不良患者的受精和妊娠率。
Chin Med J (Engl). 2012 Aug;125(16):2837-40.
2
[Correlation between serum inhibin B level after treatment with gonadotropin releasing hormone agonist and outcome of in vitro fertilization-embryo transfer].促性腺激素释放激素激动剂治疗后血清抑制素B水平与体外受精-胚胎移植结局的相关性
Zhonghua Fu Chan Ke Za Zhi. 2009 Apr;44(4):260-2.
3
A preliminary study on reduced dose (33 or 25 microg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing in vitro fertilization-embryo transfer.一项关于降低剂量(33或25微克)促性腺激素释放激素激动剂长方案用于体外受精-胚胎移植中基础血清促卵泡生成素水平高的患者多卵泡卵巢刺激的初步研究。
Gynecol Endocrinol. 2005 Oct;21(4):227-31. doi: 10.1080/09513590500282125.
4
Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles.反应不良女性的卵巢反应及妊娠结局:一项关于补充黄体生成素对体外受精周期影响的随机对照试验
Fertil Steril. 2008 Mar;89(3):546-53. doi: 10.1016/j.fertnstert.2007.03.088. Epub 2007 May 29.
5
Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in microdose cycles in poor responders.在微刺激周期中,于卵泡中期使用重组促卵泡激素联合重组促黄体生成素或低剂量重组人绒毛膜促性腺激素进行促排卵对卵巢低反应者的临床效果。
Fertil Steril. 2007 Sep;88(3):665-9. doi: 10.1016/j.fertnstert.2006.11.150. Epub 2007 Feb 12.
6
A randomized single-blind controlled trial of letrozole as a low-cost IVF protocol in women with poor ovarian response: a preliminary report.来曲唑作为低成本体外受精方案用于卵巢反应不良女性的随机单盲对照试验:初步报告
Hum Reprod. 2004 Sep;19(9):2031-5. doi: 10.1093/humrep/deh359. Epub 2004 Jun 24.
7
Reducing the dose of human chorionic gonadotropin in high responders does not affect the outcomes of in vitro fertilization.降低高反应者人绒毛膜促性腺激素的剂量不会影响体外受精的结果。
Fertil Steril. 2004 Oct;82(4):841-6. doi: 10.1016/j.fertnstert.2004.03.055.
8
Clinical and endocrine effects of ovulation induction with FSH and hCG supplementation in low responders in the midfollicular phase. A pilot study.卵泡中期低反应者使用促卵泡生成素(FSH)及补充人绒毛膜促性腺激素(hCG)进行促排卵的临床及内分泌效应:一项初步研究
J Reprod Med. 2002 Feb;47(2):137-43.
9
Ovarian stimulation and emergency in vitro fertilization for fertility preservation in cancer patients.癌症患者的生育力保存中的卵巢刺激和体外受精急症。
Eur J Obstet Gynecol Reprod Biol. 2010 Apr;149(2):175-7. doi: 10.1016/j.ejogrb.2009.12.023. Epub 2010 Jan 13.
10
[Gonadotrophin dose and ovarian response: relations to the clinical outcome of in vitro fertilization and embryo transfer].[促性腺激素剂量与卵巢反应:与体外受精和胚胎移植临床结局的关系]
Nan Fang Yi Ke Da Xue Xue Bao. 2008 May;28(5):712-4.

引用本文的文献

1
Influence of Different Gonadotropin-releasing Hormone Agonist Administration Methods on Pregnancy Outcomes of Patients Undergoing In-vitro Fertilization-embryo Transfer.不同促性腺激素释放激素激动剂给药方式对体外受精-胚胎移植患者妊娠结局的影响。
Curr Med Sci. 2019 Jun;39(3):437-441. doi: 10.1007/s11596-019-2056-9. Epub 2019 Jun 17.
2
Role of the proportion of dominant follicles in patients with polycystic ovary syndrome undergoing in vitro fertilization-embryo transfer.多囊卵巢综合征患者行体外受精-胚胎移植中主导卵泡比例的作用。
Chin Med J (Engl). 2019 Jun 20;132(12):1448-1453. doi: 10.1097/CM9.0000000000000246.
3
Progesterone elevation on the day of human chorionic gonadotropin administration adversely affects the outcome of IVF with transferred embryos at different developmental stages.
人绒毛膜促性腺激素给药当天孕酮水平升高会对不同发育阶段移植胚胎的体外受精结局产生不利影响。
Reprod Biol Endocrinol. 2015 Aug 4;13:82. doi: 10.1186/s12958-015-0075-3.
4
Serum progesterone elevation adversely affects cumulative live birth rate in different ovarian responders during in vitro fertilization and embryo transfer: a large retrospective study.血清孕酮升高对体外受精和胚胎移植过程中不同卵巢反应者的累积活产率产生不利影响:一项大型回顾性研究。
PLoS One. 2014 Jun 13;9(6):e100011. doi: 10.1371/journal.pone.0100011. eCollection 2014.